Niu J, Maurice-Dror C, Lee DH, Kim DW, et al. First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small cell lung cancer. Ann Oncol 2021 Nov 17. pii: S0923-7534(21)04776.
PMID: 34800678